132 related articles for article (PubMed ID: 30875673)
1. Potential serum biomarkers for the prediction of the efficacy of escitalopram for treating depression.
Xu Y; Wei H; Zhu Y; Zhu Y; Zhang N; Qin J; Zhu X; Yu M; Li Y
J Affect Disord; 2019 May; 250():307-312. PubMed ID: 30875673
[TBL] [Abstract][Full Text] [Related]
2. Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine.
Matrisciano F; Bonaccorso S; Ricciardi A; Scaccianoce S; Panaccione I; Wang L; Ruberto A; Tatarelli R; Nicoletti F; Girardi P; Shelton RC
J Psychiatr Res; 2009 Jan; 43(3):247-54. PubMed ID: 18511076
[TBL] [Abstract][Full Text] [Related]
3. Double-blind comparison of escitalopram and duloxetine in the acute treatment of major depressive disorder.
Khan A; Bose A; Alexopoulos GS; Gommoll C; Li D; Gandhi C
Clin Drug Investig; 2007; 27(7):481-92. PubMed ID: 17563128
[TBL] [Abstract][Full Text] [Related]
4. Plasma biomarkers in a placebo-controlled trial comparing tDCS and escitalopram efficacy in major depression.
Brunoni AR; Padberg F; Vieira ELM; Teixeira AL; Carvalho AF; Lotufo PA; Gattaz WF; Benseñor IM
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Aug; 86():211-217. PubMed ID: 29894705
[TBL] [Abstract][Full Text] [Related]
5. [Clinical efficacy and achievement of a complete remission in depression: increasing interest in treatment with escitalopram].
Favré P
Encephale; 2012 Feb; 38(1):86-96. PubMed ID: 22381728
[TBL] [Abstract][Full Text] [Related]
6. Escitalopram plasma levels and antidepressant response.
Florio V; Porcelli S; Saria A; Serretti A; Conca A
Eur Neuropsychopharmacol; 2017 Sep; 27(9):940-944. PubMed ID: 28648553
[TBL] [Abstract][Full Text] [Related]
7. Use of Machine Learning for Predicting Escitalopram Treatment Outcome From Electroencephalography Recordings in Adult Patients With Depression.
Zhdanov A; Atluri S; Wong W; Vaghei Y; Daskalakis ZJ; Blumberger DM; Frey BN; Giacobbe P; Lam RW; Milev R; Mueller DJ; Turecki G; Parikh SV; Rotzinger S; Soares CN; Brenner CA; Vila-Rodriguez F; McAndrews MP; Kleffner K; Alonso-Prieto E; Arnott SR; Foster JA; Strother SC; Uher R; Kennedy SH; Farzan F
JAMA Netw Open; 2020 Jan; 3(1):e1918377. PubMed ID: 31899530
[TBL] [Abstract][Full Text] [Related]
8. Escitalopram for severe asthma and major depressive disorder: a randomized, double-blind, placebo-controlled proof-of-concept study.
Brown ES; Howard C; Khan DA; Carmody TJ
Psychosomatics; 2012; 53(1):75-80. PubMed ID: 22221724
[TBL] [Abstract][Full Text] [Related]
9. Neurotrophic factors in depression in response to treatment.
Buttenschøn HN; Foldager L; Elfving B; Poulsen PH; Uher R; Mors O
J Affect Disord; 2015 Sep; 183():287-94. PubMed ID: 26047306
[TBL] [Abstract][Full Text] [Related]
10. Association of BDNF, HTR2A, TPH1, SLC6A4, and COMT polymorphisms with tDCS and escitalopram efficacy: ancillary analysis of a double-blind, placebo-controlled trial.
Brunoni AR; Carracedo A; Amigo OM; Pellicer AL; Talib L; Carvalho AF; Lotufo PA; Benseñor IM; Gattaz W; Cappi C
Braz J Psychiatry; 2020 Apr; 42(2):128-135. PubMed ID: 31721892
[TBL] [Abstract][Full Text] [Related]
11. Whole-genome expression analysis reveals genes associated with treatment response to escitalopram in major depression.
Pettai K; Milani L; Tammiste A; Võsa U; Kolde R; Eller T; Nutt D; Metspalu A; Maron E
Eur Neuropsychopharmacol; 2016 Sep; 26(9):1475-1483. PubMed ID: 27461515
[TBL] [Abstract][Full Text] [Related]
12. Early reactions of brain-derived neurotrophic factor in plasma (pBDNF) and outcome to acute antidepressant treatment in patients with Major Depression.
Dreimüller N; Schlicht KF; Wagner S; Peetz D; Borysenko L; Hiemke C; Lieb K; Tadić A
Neuropharmacology; 2012 Jan; 62(1):264-9. PubMed ID: 21803060
[TBL] [Abstract][Full Text] [Related]
13. A pharmacoeconomic evaluation of escitalopram versus citalopram in the treatment of severe depression in the United Kingdom.
Wade AG; Toumi I; Hemels ME
Clin Ther; 2005 Apr; 27(4):486-96. PubMed ID: 15922821
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorder.
Leuchter AF; Cook IA; Gilmer WS; Marangell LB; Burgoyne KS; Howland RH; Trivedi MH; Zisook S; Jain R; Fava M; Iosifescu D; Greenwald S
Psychiatry Res; 2009 Sep; 169(2):132-8. PubMed ID: 19709754
[TBL] [Abstract][Full Text] [Related]
15. Citalopram and escitalopram in the treatment of major depressive disorder: a pooled analysis of 3 clinical trials.
Li H; Li T; Li G; Luo J
Ann Clin Psychiatry; 2014 Nov; 26(4):281-7. PubMed ID: 25401715
[TBL] [Abstract][Full Text] [Related]
16. Effects of escitalopram on serum BDNF levels in elderly patients with depression: a preliminary report.
Martocchia A; Curto M; Scaccianoce S; Comite F; Xenos D; Nasca C; Falaschi GM; Ferracuti S; Girardi P; Nicoletti F; Falaschi P
Aging Clin Exp Res; 2014 Aug; 26(4):461-4. PubMed ID: 24435333
[TBL] [Abstract][Full Text] [Related]
17. Serum brain-derived neurotrophic factor predicts responses to escitalopram in chronic posttraumatic stress disorder.
Berger W; Mehra A; Lenoci M; Metzler TJ; Otte C; Tarasovsky G; Mellon SH; Wolkowitz OM; Marmar CR; Neylan TC
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Oct; 34(7):1279-84. PubMed ID: 20643177
[TBL] [Abstract][Full Text] [Related]
18. [Severe forms of depression: the efficacy of escitalopram].
Spadone C
Encephale; 2009 Apr; 35(2):152-9. PubMed ID: 19393384
[TBL] [Abstract][Full Text] [Related]
19. An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline.
Uher R; Tansey KE; Dew T; Maier W; Mors O; Hauser J; Dernovsek MZ; Henigsberg N; Souery D; Farmer A; McGuffin P
Am J Psychiatry; 2014 Dec; 171(12):1278-86. PubMed ID: 25017001
[TBL] [Abstract][Full Text] [Related]
20. Antidepressant drug-specific prediction of depression treatment outcomes from genetic and clinical variables.
Iniesta R; Hodgson K; Stahl D; Malki K; Maier W; Rietschel M; Mors O; Hauser J; Henigsberg N; Dernovsek MZ; Souery D; Dobson R; Aitchison KJ; Farmer A; McGuffin P; Lewis CM; Uher R
Sci Rep; 2018 Apr; 8(1):5530. PubMed ID: 29615645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
